Can Thiopurines Prevent Formation of Antibodies Against Tumor Necrosis Factor Antagonists After Failure of These Therapies?

Clin Gastroenterol Hepatol. 2017 Jan;15(1):76-78. doi: 10.1016/j.cgh.2016.09.152. Epub 2016 Oct 5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibody Formation
  • Crohn Disease*
  • Humans
  • Infliximab*
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab